Bespoke Extracts (BSPK) Other Non-Current Assets (2012 - 2025)
Bespoke Extracts (BSPK) reported Other Non-Current Assets of $12000.0 for Q3 2025, little changed on a YoY basis from $12000.0 in Q3 2024, and little changed sequentially from $12000.0 in Q2 2025.
Bespoke Extracts (BSPK) Other Non-Current Assets (2012 - 2025) Analysis & Trends
Bespoke Extracts (BSPK) has 5 years of Other Non-Current Assets data on file, last reported at $12000.0 in Q3 2025.
- For the quarter ending Q3 2025, Other Non-Current Assets changed 0.0% year-over-year to $12000.0; the trailing twelve-month figure through Sep 2025 stood at $12000.0 (changed 0.0% YoY), and the FY2024 full-year result was $12000.0, changed 0.0% from the prior year.
- Other Non-Current Assets was little changed at $12000.0 in Q3 2025, from $12000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $13416.0 in Q3 2022 to a low of $12000.0 in Q1 2022.
- A 4-year average of $12142.3 and a median of $12000.0 in 2022 frame the typical range for Other Non-Current Assets.
- Peak annual rise in Other Non-Current Assets reached 0.0% in 2023, while the deepest fall reached 10.55% in 2023.
- Tracing BSPK's Other Non-Current Assets over 4 years: stood at $12000.0 in 2022, then changed by 0.0% to $12000.0 in 2023, then changed by 0.0% to $12000.0 in 2024, then changed by 0.0% to $12000.0 in 2025.
- Business Quant data shows BSPK's Other Non-Current Assets at $12000.0 in Q3 2025, $12000.0 in Q2 2025, and $12000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 49.22 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.79 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 351.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 491.06 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 233.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.11 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 73.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 295.00 Mn |
| 10 | Bespoke Extracts | 1.12 Mn | 1.11 Mn | 234,175.00 | 12,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 12,000.00 |
| Jun 30, 2025 | 12,000.00 |
| Mar 31, 2025 | 12,000.00 |
| Dec 31, 2024 | 12,000.00 |
| Sep 30, 2024 | 12,000.00 |
| Jun 30, 2024 | 12,000.00 |
| Mar 31, 2024 | 12,000.00 |
| Dec 31, 2023 | 12,000.00 |
| Sep 30, 2023 | 12,000.00 |
| Jun 30, 2023 | 12,000.00 |
| Mar 31, 2023 | 12,000.00 |
| Dec 31, 2022 | 12,000.00 |
| Sep 30, 2022 | 13,416.00 |
| Jun 30, 2022 | 12,719.00 |
| Mar 31, 2022 | 12,000.00 |
| Aug 31, 2012 | 11,000.00 |
| May 31, 2012 | 6,000.00 |